Upcoming Webinars
-
Ripped from the Headlines: Hot Topics in Life Sciences 2026
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter. Join Medmarc's Risk Managers to discuss these changes from 2026.
Register for Ripped from the Headlines: Hot Topics in Life Sciences 2026 Read More about Ripped from the Headlines: Hot Topics in Life Sciences 2026 -
Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Join Andy Hall as he gives an update on the claims and legal environment for life science companies.
Register for Claims 2026: Navigating an Increasingly Difficult World for Life Sciences Read More about Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Past Webinars
-
Verification & Testing Strategies For Compliance With ISO 13485:2016, IEC 62304 / 60601-1 / 82304-1
This webinar will cover the following topics: What types of medical devices will require verification testing, and how to identify what standards your device needs to test to. Key aspects of these...
Read More about Verification & Testing Strategies For Compliance With ISO 13485:2016, IEC 62304 / 60601-1 / 82304-1 -
Out of EUA— FDA’s Guidance & Recommendations
In our webinar held last July about the FDA’s Emergency Use Authorization (“EUA”), presenter Jianlin Song predicted that, as we get closer to the end of the pandemic, the FDA would release guidelines...
Read More about Out of EUA— FDA’s Guidance & Recommendations -
How to Effectively Evaluate Change and Incorporate Findings into Biocompatibility Testing and Justifications
Change Management, especially related to a medical device’s design, is one of the most commonly-cited issues in FDA 483s and Warning Letters. Unfortunately, change is constant in the medical device...
Read More about How to Effectively Evaluate Change and Incorporate Findings into Biocompatibility Testing and Justifications -
FDA Outlook for 2022
The US Food and Drug Administration (FDA) continues to juggle enormous Covid-related responsibilities, while simultaneously attempting to make progress on a huge number of important regulatory...
Read More about FDA Outlook for 2022